Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Actinium has successfully completed the second module of its previously announced research and option agreement with Astellas Pharma and the third module has been initiated.
read more
Biokin Pharmaceutical and Cryoport announced Cryoport's temperature-controlled solutions will support Biokin Pharma's pending Phase I and II clinical trials in immuno-oncology in both the U.S. and China.
read more
A critical focus for the FDA is preventing and mitigating potential medical product shortages.
read more
Selvita announced it plans to separate into two companies.
read more
OcellO has entered an agreement to provide in vitro research services to Merus, a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics.
read more
Wednesday, March 27, 2019
STA Pharmaceutical WuXi STA announces its new drug product manufacturing facility in Waigaoqiao Free Trade Zone of Shanghai has passed its first GMP inspection by the European MPA.
read more
Wednesday, March 27, 2019
Worldwide Clinical Trials announced Shaolian Zhou, Ph.D., has joined the company as senior vice president and lab director for Bioanalytical Services.
read more
Wednesday, March 27, 2019
XenTech SAS announced a strategic collaboration with Gustave Roussy in Europe.
read more
Wednesday, March 27, 2019
Lonza has introduced CellBio Services, a comprehensive portfolio of unique, custom solutions designed to meet specific, individual research application needs.
read more
Wednesday, March 27, 2019
Cambrex announced it will double the liquid packaging capacity and weekly output at its Mirabel, Québec site in Canada.
read more
Wednesday, March 27, 2019
Crown Bioscience announced that parent company, JSR Corporation, has entered into a strategic partnership with Hubrecht Organoid Technology (HUB).
read more
TCR2 Therapeutics has selected the advanced therapy medicinal products ecosystem in the United Kingdom (UK) to establish a site for global manufacturing systems and capabilities.
read more
Abzena has signed an agreement to support an integrated CMC program with Lipum, a company developing treatments for chronic inflammatory diseases.
read more
LabConnect has appointed Dr. Anthony Todd Everhart to serve as medical director.
read more
Veeda Clinical Research announced their clinical (Shivalik, Ahmedabad) and Bioanalytical facilities (Insignia, Ahmedabad) have successfully completed the third inspection by NPRA.
read more